baicalin has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Dou, Y; Liu, C; Qu, J; Shang, Y; Shen, Y | 1 |
1 other study(ies) available for baicalin and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
Topics: Animals; Biomarkers; Cell Line; Cell Movement; Doxorubicin; Epithelial-Mesenchymal Transition; Female; Flavonoids; Glomerulosclerosis, Focal Segmental; Kidney Glomerulus; Male; Mice; Mice, Inbred BALB C; Podocytes; Proteinuria; Receptor, Notch1; Snail Family Transcription Factors; Transforming Growth Factor beta1 | 2020 |